58670 Federal Register / Vol. 72, No. 199 / Tuesday, October 16, 2007 / Notices 

recommend improvements in the 

national newborn and childhood 

heritable screening programs, and to 

engage in the following activities: 

(1) Provide advice and 

recommendations to the Secretary 

concerning grants and projects awarded 

or funded under its designated 

authorizing PHS Act; 

(2) Provide technical information to 

the Secretary for the development of 

policies and priorities for the 

administration of grants under the 

designated PHS act; and 

(3) Provide such recommendations, 

advice or information as may be 

necessary to enhance, expand or 

improve the ability of the Secretary to 

reduce the mortality or morbidity in 

newborns and children from heritable 

disorders. 

The purpose of this call is to hear 

discussion from the ACHDGDNC 

members on the proposed review 

template from the ACHDGDNC’s 

Evidence Workgroup and, if the 

ACHDGDNC chooses, to approve that 

template. In addition, the ACHDGDNC 

may choose to develop 

recommendations from the ACHDGDNC 

to the Secretary concerning the 

ACHDGDNC’s evaluation and 

decisionmaking process and newborn 

screening long-term followup. 

Dated: October 9, 2007. 

Alexandra Huttinger, 

Acting Director, Division of Policy Review 

and Coordination. 

[FR Doc. E7–20387 Filed 10–15–07; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the President’s Cancer 

Panel, October 22, 2007, 8 a.m. to 

October 22, 2007, 6:30 p.m., Hyatt 

Regency La Jolla, 3777 La Jolla Village 

Drive, San Diego, CA 92122 which was 

published in the Federal Register on 

September 26, 2007, 72 FR 54667. 

This meeting is being amended to 

reschedule the closed session to 

Tuesday, October 30, 2007, 2 p.m.–4 

p.m., as a telephone conference. The 

meeting is closed to the public. 

Dated: October 5, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5093 Filed 10–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Board of 

Scientific Advisors. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: November 15–16, 2007. 

Time: November 15, 2007, 8 a.m. to 6 p.m. 

Agenda: Director’s Report: Ongoing and 

New Business; Reports of Program Review 

Group(s); and Budget Presentation; Reports of 

Special Initiatives; RFA and RFP Concept 

Reviews; and Scientific Presentations. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th Floor, 

Conference Room 10, Bethesda, MD 20892. 

Time: November 16, 2007, 8:30 a.m. to 1 

p.m. 

Agenda: Reports of Special Initiatives; RFA 

and RFP Concept Reviews; and Scientific 

Presentations. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, 6th Floor, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Paulette S. Gray, PhD, 

Executive Secretary, Director, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, RM. 8001, 

Bethesda, MD 20892, 301–496–5147, 

grayp@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: 

deainfo.nci.nih.gov/advisory/bsa.htm, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic 

Assistance Program Nos. 93.392, Cancer 

Construction; 93.393, Cancer Cause and 

Prevention Research; 93.394, Cancer 

Detection and Diagnosis Research; 

93.395, Cancer Treatment Research; 

93.396, Cancer Biology Research; 

93.397, Cancer Centers Support; 93.398, 

Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of 

Health, HHS) 

Dated: October 10, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5095 Filed 10–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Conference Grant SEP. 

Date: October 31, 2007. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Room—1087, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Steven Birken, PhD, 

Scientific Review Administrator, Office of 

Review, National Center for Research 

Resources, National Institutes of Health, 6701 

Democracy Blvd., 10th Fl., Bethesda, MD 

20892, (301) 435–1078, 

birkens@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

C.O.B.R.E.—SEP. 

Date: November 1, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Linda C. Duffy, PhD, 

Scientific Review Administrator, Office of 

Review, National Center for Research 

Resources, National Institutes of Health, 6701 

Dem. Blvd., 1 Dem, Plaza, Rm. 1082, MSC 

4874, Bethesda, MD 20892–4874, 301–435–

0810, duffyl@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

Comparative Medicine SEP. 

Date: November 7, 2007. 

Time: 2:30 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

mmaher on PROD1PC70 with NOTICES

Federal Register / Vol. 72, No. 199 / Tuesday, October 16, 2007 / Notices 58671 

Boulevard, Room—1087, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Steven Birken, PhD, 

Scientific Review Administrator, National 

Center for Research Resources, or National 

Institutes of Health, 6701 Democracy 

Boulevard, One Democracy Plaza, Room 

1078, MSC 4874, Bethesda, MD 20892–4874, 

301–435–0815, birkens@mail.nih.gov. 

Name of Committee: National Center for 

Research Resources Special Emphasis Panel; 

CM SEP 08’. 

Date: November 19, 2007. 

Time: 2 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 1 

Democracy Plaza, 6701 Democracy Blvd., 

1087, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Steven Birken, PhD, 

Scientific Review Administrator, National 

Center for Research Resources, or National 

Institutes of Health, 6701 Democracy 

Boulevard, One Democracy Plaza, Room 

1078, MSC 4874, Bethesda, MD 20892–4874, 

301–435–0815, birkens@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

93.306, 93.333, National Institutes of Health, 

HHS) 

Dated: October 5, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5089 Filed 10–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Sickle Cell Disease Advisory 

Committee. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Sickle Cell Disease 

Advisory Committee. 

Date: October 29, 2007. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: Discussion of Programs and 

Issues. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Conference Room 9112/ 

9116, Bethesda, MD 20892. 

Contact Person: Robert B Moor, PhD, 

Health Scientist Administrator, Blood 

Diseases Program, Division of Blood Disease 

and Resources, National Heart, Lung, and 

Blood Institute, NIH, 6701 Rockledge Drive, 

Room 10162, Bethesda, MD 20892, 301/435–

0050. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nhlbi.nih.gov/meetings/index.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 933.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: October 3, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5084 Filed 10–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; MBRS Support of Competitive 

Research. 

Date: October 23–24, 2007. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892. (Telephone Conference Call). 

Contact Person: Margaret J Weidman, PhD, 

Office of Scientific Review, National Institute 

of General Medical Sciences, National 

Institutes of Health, 45 Center Drive, Room 

3AN18B, Bethesda, MD 20892, 301 594–

3663, weidmanma@nigms.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: October 5, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5083 Filed 10–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Alzheimer 

Pathogenesis. 

Date: October 24, 2007. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20814 (Telephone 

Conference Call). 

Contact Person: William Cruce, PhD, 

Health Scientist Administrator, Scientific 

Review Office, National Institute on Aging, 

National Institutes of Health, Room 2C212, 

7201 Wisconsin Avenue, Bethesda, MD 

20814, 301–402–7704, crucew@nia.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

mmaher on PROD1PC70 with NOTICES